arrow
E

Elizabeth R. Unger

Centers for Disease Control and Prevention
H指数:70
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterizing Pediatric Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Symptom Burden, Functional Impairment, and Comparison With Adults in the Multi-Site Clinical Assessment of ME/CFS (MCAM) Study

儿科肌痛性脑脊髓炎/慢性疲劳综合征的特征:症状负担、功能损害与成人比较——来自多中心ME/CFS临床评估研究(MCAM)

2026-10-060
OA
Seroprevalence of nine human papillomavirus types included in the nonavalent vaccine in unvaccinated women living in Puerto Rico: A population-based study

九价人乳头瘤病毒疫苗包含的九种人乳头瘤病毒类型的血清流行率:一项基于人群的研究,研究对象为居住在波多黎各的未接种疫苗女性

2025-11-100
OAAI
Human Papillomavirus Vaccine Effectiveness by Age, Age at Vaccination, and Timing of Vaccination Relative to Age at First Sex Among Men Who Have Sex With Men-Seattle, Washington, 2018 to 2020

人类乳头瘤病毒疫苗有效性研究:基于年龄、接种年龄以及相对于首次性行为年龄的接种时间——以男性同性性行为者(Seattle, Washington, 2018-2020)

2025-10-010
PRE
Vaccine Effectiveness Against Anal HPV Infection Among Men With HIV Who Have Sex With Men Attending Sexual Health Clinics in Three US Cities, 2018–2023

2018–2023年,在美国三座城市性健康诊所就诊的HIV感染者男性同性性行为者中,疫苗对肛门HPV感染的预防效果

2025-08-150
PRE
Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohort study

九价人乳头瘤病毒疫苗两剂次接种后阿拉斯加原住童的免疫原性和抗体持续时间:一项前瞻性队列研究

2025-04-300
OA